Enoxaparin sodium biosimilar (Blau Pharmaceuticals)
依诺肝素钠生物类似药 (Blau Pharmaceuticals)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameEnoxaparin sodium biosimilar (Blau Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2013/07/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBlau Pharmaceuticals
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A